Boston Scientific Corp (WBO:BSXC)
€ 86 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 70/100

Boston Scientific Corp at Stifel Healthcare Conference Transcript

Nov 14, 2023 / 01:00PM GMT
Release Date Price: €49.69 (+3.89%)
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Good morning, everybody. Welcome to Stifel's Annual Healthcare Conference. My name is Rick Wise. I'm one of a group of excellent, I hope, medtech analysts here at Stifel. And it is my sincere pleasure to welcome 2 outstanding members of the Boston Scientific team. To my left, Dan Brennan, Chief Financial Officer. And to his left, to Dan's left, Lauren Tengler, Head of Investor Relations, and there are many other titles, but we'll just focus on that. And thank you for both being here to open up this year's conference.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

I appreciate the invitation. Pleasure to be here as always, Rick.

Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Thank you, Dan. And I mean, this has been quite an extraordinary period for Boston. I appreciated your recent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot